Biomarkers for Palbociclib in Fulvestrant-Resistant Metastatic Breast Cancer Using cfDNA Cancer Panel Sequencing

被引：0
|
作者：
Takeshita, Takashi [1 ]
Iwamoto, Takayuki [2 ]
Niikura, Naoki [3 ]
Watanabe, Kenichi [4 ]
Kikawa, Yuichiro [5 ]
Kobayashi, Kokoro [6 ]
Okamura, Takuho [3 ]
Tada, Hiroshi [7 ]
Ozaki, Shinji [8 ]
Toh, Uhi [9 ]
Yamamoto, Yutaka [1 ]
Tsuneizumi, Michiko [10 ]
Ishiguro, Hiroshi [11 ]
Masuda, Norikazu [12 ]
Saji, Shigehira [13 ]
机构：
[1] Kumamoto City Hosp, Dept Breast & Endcrine Surg, Kumamoto, Japan
[2] Kawasaki Med Sch Hosp, Dept Breast & Thyroid Surg, Kawasaki, Japan
[3] Tokai Univ, Sch Med, Dept Breast Oncol, Tokai, Japan
[4] NHO Hokkaido Canc Ctr, Det Breast Oncol, Sapporo, Japan
[5] Kansai Med Univ Hosp, Dept Breast Surg, Hirakata, Japan
[6] Saitama Red Cross Hosp, Dept Med Oncol, Saitama, Japan
[7] Tohoku Univ Hosp, Dept Breast & Endocrine Surg, Sendai, Japan
[8] Hiroshima Prefectural Hosp, Dept Gastrointestinal & Breast Surg, Hiroshima, Japan
[9] Kurume Univ, Hosp Dept Breast Surg, Kurume, Japan
[10] Shizuoka Prefectural Gen Hosp, Dept Breast Surg, Shizuoka, Japan
[11] Saitama Med Univ, Int Med Ctr, Breast Oncol Serv, Saitama, Japan
[12] Kyoto Univ, Grad Sch, Dept Breast Surg, Med Div, Kyoto, Japan
[13] Fukushima Med Univ, Sch Med, Dept Med Oncol, Fukushima, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3050
引用
收藏
页码：1890 / 1890
页数：1
相关论文
共 50 条
  • [21] Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients
    Lauren Darrigues
    Jean-Yves Pierga
    Alice Bernard-Tessier
    Ivan Bièche
    Amanda Bartolini Silveira
    Marc Michel
    Delphine Loirat
    Paul Cottu
    Luc Cabel
    Coraline Dubot
    Romain Geiss
    Francesco Ricci
    Anne Vincent-Salomon
    Charlotte Proudhon
    François-Clément Bidard
    Breast Cancer Research, 23
  • [22] Fulvestrant in metastatic breast cancer.
    Steger, GG
    Bartsch, R
    Wenzel, C
    Pluschnig, U
    Hussian, D
    Mader, RM
    Zielinski, CC
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S104 - S104
  • [23] Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer
    Pauline du Rusquec
    Clément Palpacuer
    Loic Campion
    Anne Patsouris
    Paule Augereau
    Carole Gourmelon
    Marie Robert
    Laurence Dumas
    Folliard Caroline
    Mario Campone
    Jean-Sébastien Frenel
    Breast Cancer Research and Treatment, 2018, 168 : 559 - 566
  • [24] SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer
    Carla L. Alves
    Daniel Elias
    Maria B. Lyng
    Martin Bak
    Henrik J. Ditzel
    Breast Cancer Research, 20
  • [25] Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer
    du Rusquec, Pauline
    Palpacuer, Clement
    Campion, Loic
    Patsouris, Anne
    Augereau, Paule
    Gourmelon, Carole
    Robert, Marie
    Dumas, Laurence
    Caroline, Folliard
    Campone, Mario
    Frenel, Jean-Sebastien
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 559 - 566
  • [26] SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer
    Alves, Carla L.
    Elias, Daniel
    Lyng, Maria B.
    Bak, Martin
    Ditzel, Henrik J.
    BREAST CANCER RESEARCH, 2018, 20
  • [27] Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
    Mehta, Rita S.
    Barlow, William E.
    Albain, Kathy S.
    Vandenberg, Ted A.
    Dakhil, Shaker R.
    Tirumali, Nagendra R.
    Lew, Danika L.
    Hayes, Daniel F.
    Gralow, Julie R.
    Livingston, Robert B.
    Hortobagyi, Gabriel N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05): : 435 - 444
  • [28] Fulvestrant plus capivasertib for metastatic breast cancer
    Dekker, Tim Johannes Adrianus
    LANCET ONCOLOGY, 2020, 21 (05): : E232 - E232
  • [29] Anastrozole and Fulvestrant in Metastatic Breast Cancer REPLY
    Mehta, Rita S.
    Barlow, William E.
    Hortobagyi, Gabriel N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1663 - 1664
  • [30] An evaluation of fulvestrant for the treatment of metastatic breast cancer
    Soleja, Mohsin
    Raj, Ganesh V.
    Unni, Nisha
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (15) : 1819 - 1829
12345